Roberta Champouillon
Family · Albuquerque, NMNPI 1134850779
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $30.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$955
- AbbVie$902
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$859
- Novo Nordisk$472
- Alkermes, Inc.$423
- Teva Pharmaceuticals USA, Inc.$376
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,90498%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $955 |
| AbbVie(2 entities) | 54 | $902 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $859 |
| Novo Nordisk | 19 | $472 |
| Alkermes, Inc. | 4 | $423 |
| Teva Pharmaceuticals USA, Inc. | 5 | $376 |
| Lilly USA, LLC | 17 | $375 |
| Idorsia Pharmaceuticals US Inc | 8 | $332 |
| Otsuka America Pharmaceutical, Inc. | 7 | $233 |
| Exact Sciences | 10 | $223 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $161 |
| Astellas Pharma US Inc | 5 | $127 |
| Sanofi | 1 | $125 |
| Argenx US, Inc. | 1 | $100 |
| Acella Pharmaceuticals, LLC | 5 | $77 |
| Pfizer | 4 | $69 |
| Novartis | 2 | $37 |
| Lundbeck LLC | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Angiodynamics, Inc. | 1 | $25 |
| Merck | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,003 in reported general payments places this provider in the 95th percentile of 1,080 family providers in New Mexico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 73 | $2,486 |
| Levothyroxine Sodium | 72 | $1,096 |
| Gabapentin | 58 | $659 |
| Tramadol Hcl | 28 | $592 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $420 |
| Amitriptyline Hcl | 12 | $379 |
| Fluticasone Propionate | 16 | $364 |
| Atorvastatin Calcium | 23 | $320 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $313 |
| Propranolol Hcl | 13 | $299 |
| Lisinopril | 48 | $296 |
| Amlodipine Besylate | 44 | $267 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 19 | $230 |
| Metformin Hcl | 43 | $223 |
| Hydrochlorothiazide | 23 | $222 |
Paid to pharmacies, not to this prescriber.
Other family in Albuquerque
- Barbara FranklinAlbuquerque$28K
- Melanie DuranAlbuquerque$15K
- Irasema LlewellynAlbuquerque$14K
- Charles GallegosAlbuquerque$10K
- Marlyn NewbyAlbuquerque$9K
- Annmarie FoleyAlbuquerque$8K
- Aimee CasarezAlbuquerque$7K
- Rita SuharliAlbuquerque$6K
- Matthew TotterAlbuquerque$6K
- Genevieve DavisAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.